BPC-157 (Body Protection Compound-157)
BPC-157 is a synthetic 15-amino-acid gastric pentadecapeptide with a molecular weight of 1,419.53 Da, derived from a protective protein in human…
7 sources
Research-backed articles on peptide therapeutics, clinical findings, and compound profiles. Every claim cited. Every source verified. Built for practitioners and informed patients.
100%
Source-Cited Content
PubMed
Primary Source Database
Expert
Reviewed Before Publishing
Daily
Research Updates
BPC-157 is a synthetic 15-amino-acid gastric pentadecapeptide with a molecular weight of 1,419.53 Da, derived from a protective protein in human…
7 sources
CJC-1295 is a synthetic 29-amino-acid GHRH analog available in two forms: with and without Drug Affinity Complex (DAC), yielding half-lives of 6-8…
3 sources
GHK-Cu is a naturally occurring tripeptide-copper complex that modulates expression of over 4,000 human genes. Research using the Broad Institute…
4 sources
BPC-157, a synthetic peptide derived from gastric proteins, shows promising potential for accelerating soft tissue healing in preclinical studies…
11 sources
GLP-1 receptor agonists have emerged as powerful tools for managing type 2 diabetes and obesity, with growing evidence suggesting benefits beyond…
20 sources
NAD+ is a crucial molecule that powers your cells and influences aging, metabolism, and longevity. Discover how this cellular fuel works and what…
20 sources
Antimicrobial peptides (AMPs) are emerging as promising alternatives to conventional antibiotics in the fight against drug-resistant infections…
5 sources
Preclinical rat studies demonstrate that BPC-157, a gastric pentadecapeptide, accelerates Achilles tendon and medial collateral ligament healing…
5 sources
Multiple systematic reviews and meta-analyses of randomized controlled trials demonstrate that oral collagen peptide supplementation significantly…
4 sources
Artificial intelligence is transforming peptide drug discovery, with billion-dollar pharma deals, generative AI design tools, and over 78 percent of…
5 sources
The FDA has cracked down on compounded GLP-1 agonists following shortage resolutions, while Congress has introduced the SAFE Drugs Act proposing…
5 sources
The FDA's reclassification of 12 peptides from Category 2 restrictions in April 2026 has reopened the door for compounding pharmacies. With the…
5 sources
New research summaries, compound profiles, and industry news published regularly. All content is evidence-based and source-cited.